News | Harvard Office of Technology Development

March 20, 2018
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
Tags:
bioengineering,cancer,david mooney,licensing,sponsored research
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
July 27, 2017
Sticky when wet: A strong adhesive for wound healing
Tags:
david mooney,materials,medical devices
Medical-grade bio-glue inspired by slugs sticks to biological surfaces without toxicity
November 30, 2015
A better way to change the fate of stem cells
Tags:
david mooney,materials,stem cells
Harvard researchers have developed a new, more precise way to control the differentiation of stem cells into bone cells.